1例采用高危治疗方案治疗的重排B淋巴细胞淋巴瘤儿科病例。 - Suppr

A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.

作者信息

Murphy Lindsey, Siegele Bradford, Carstens Billie, Hartman Lisa, Faulk Kelly

机构信息

Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

Department of Pathology and Laboratory Medicine, Children's Hospital Colorado and Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

出版信息

Leuk Lymphoma. 2024 Jun;65(6):843-847. doi: 10.1080/10428194.2024.2315159. Epub 2024 Feb 19.

DOI:10.1080/10428194.2024.2315159

PMID:38372299

Abstract

摘要

相似文献

A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.

Leuk Lymphoma. 2024 Jun;65(6):843-847. doi: 10.1080/10428194.2024.2315159. Epub 2024 Feb 19.

MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.

Leuk Lymphoma. 2017 Jun;58(6):1498-1501. doi: 10.1080/10428194.2016.1246728. Epub 2016 Oct 24.

Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia.

Pediatr Blood Cancer. 2024 Jun;71(6):e30964. doi: 10.1002/pbc.30964. Epub 2024 Mar 21.

B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.

Am J Hematol. 2020 Nov;95(11):1427-1429. doi: 10.1002/ajh.25801. Epub 2020 Apr 15.

Romidepsin enhances the efficacy of cytarabine , revealing histone deacetylase inhibition as a promising therapeutic strategy for -rearranged infant acute lymphoblastic leukemia.

Haematologica. 2019 Jul;104(7):e300-e303. doi: 10.3324/haematol.2018.192906. Epub 2019 Jan 24.

Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in -rearranged acute lymphoblastic leukemia: a case report and review of the literature.

Leuk Lymphoma. 2019 Jul;60(7):1827-1830. doi: 10.1080/10428194.2018.1562185. Epub 2019 Jan 7.

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.

Leukemia. 2024 Jul;38(7):1600-1603. doi: 10.1038/s41375-024-02209-7. Epub 2024 Mar 22.

Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.

Histopathology. 2024 Aug;85(2):310-316. doi: 10.1111/his.15203. Epub 2024 Apr 30.

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.

Leuk Lymphoma. 2017 Jan;58(1):145-152. doi: 10.1080/10428194.2016.1177182. Epub 2016 Apr 27.

Extramedullary relapse of ()-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab.

Blood. 2018 May 31;131(22):2507. doi: 10.1182/blood-2018-02-834911.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.

作者信息

Murphy Lindsey, Siegele Bradford, Carstens Billie, Hartman Lisa, Faulk Kelly

机构信息

Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

Department of Pathology and Laboratory Medicine, Children's Hospital Colorado and Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

出版信息

Leuk Lymphoma. 2024 Jun;65(6):843-847. doi: 10.1080/10428194.2024.2315159. Epub 2024 Feb 19.

DOI:10.1080/10428194.2024.2315159

PMID:38372299

Abstract

摘要

相似文献

A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.

Leuk Lymphoma. 2024 Jun;65(6):843-847. doi: 10.1080/10428194.2024.2315159. Epub 2024 Feb 19.

MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.

Leuk Lymphoma. 2017 Jun;58(6):1498-1501. doi: 10.1080/10428194.2016.1246728. Epub 2016 Oct 24.

Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia.

Pediatr Blood Cancer. 2024 Jun;71(6):e30964. doi: 10.1002/pbc.30964. Epub 2024 Mar 21.

B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.

Am J Hematol. 2020 Nov;95(11):1427-1429. doi: 10.1002/ajh.25801. Epub 2020 Apr 15.

Romidepsin enhances the efficacy of cytarabine , revealing histone deacetylase inhibition as a promising therapeutic strategy for -rearranged infant acute lymphoblastic leukemia.

Haematologica. 2019 Jul;104(7):e300-e303. doi: 10.3324/haematol.2018.192906. Epub 2019 Jan 24.

Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in -rearranged acute lymphoblastic leukemia: a case report and review of the literature.

Leuk Lymphoma. 2019 Jul;60(7):1827-1830. doi: 10.1080/10428194.2018.1562185. Epub 2019 Jan 7.

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.

Leukemia. 2024 Jul;38(7):1600-1603. doi: 10.1038/s41375-024-02209-7. Epub 2024 Mar 22.

Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.

Histopathology. 2024 Aug;85(2):310-316. doi: 10.1111/his.15203. Epub 2024 Apr 30.

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.

Leuk Lymphoma. 2017 Jan;58(1):145-152. doi: 10.1080/10428194.2016.1177182. Epub 2016 Apr 27.

Extramedullary relapse of ()-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab.

Blood. 2018 May 31;131(22):2507. doi: 10.1182/blood-2018-02-834911.

A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.

作者信息

机构信息

出版信息

相似文献